BPC-157 Arginate — preclinical research summary

BPC-157 Arginate — oral stability data.

Preclinical stability and absorption data. Every number links to its source.

Open the research library →

The research landscape

Mapped from published science.

6
Support pathways mapped
8
Active compounds
3
Formula layers
20+
Studies referenced
9,543
subjects · SNAC (preclinical) delivery
1,996
subjects · PEA (preclinical)
-70%
gut permeability · Zinc-L-Carnosine

Architecture

Research compound architecture.
Multi-pathway preclinical data.

Tissue repair, gut barrier integrity, collagen synthesis, and anti-inflammatory signaling — all preclinical data. — combined into a single research compound formulation.

Explore preclinical research →

BPC-157 Arginate

The stabilized form.

*Backed by an ongoing peer-reviewed preclinical research.

BPC-157 research →

Ac-SDKP (TB4-derived tetrapeptide)

Ac-SDKP — a distinct research tetrapeptide.

Oral bioavailability characterized in preclinical models.

Fragment research →

PEA

Anti-inflammatory profile (preclinical).

PEA is included as the anti-inflammatory (preclinical)-siUp to 35% less anti-inflammatory (preclinical), month one — studied across 1,196 research subjects.

PEA research →

Gut barrier logic

The gut is a barrier,
not just a tube.

Zinc-L-Carnosine cut gut permeability by 70% in 14 days.

Gut barrier research →

Oral delivery logic

Built to survive the stomach.

×9 absorption with SNAC — the only oral peptide delivery technology approved by the FDA.

Delivery research →

Real science. Real authors.

The compounds in our formulas are studied by researchers at established institutions. We cite them — names, institutions, and work.

Researchers

RESEARCHERS

Experts in peptide science and peptide and biochemistry research

Research Data

RESEARCH DATA

Advanced Analytical Testing and Compound Verification

Published Research

PUBLISHED RESEARCH

Peer-reviewed studies in reputable research journals

Established Institutions

ESTABLISHED INSTITUTIONS

Collaborations with leading research institutions worldwide

Up to 20 cited authors / institutions populated during research phase. → See all sources

Research context

Published studies on compound classes.

Publicly available peer-reviewed research on these compound classes.. All data is preclinical. No human clinical trials conducted by Panstellar LLC.

Studies relevant to these compound classes are catalogued in our Research Library.

Compound comparison — research architecture

Research architecture comparison.

SignalInjectionComparator formulationPanstellar
No needles✗✓✓
Oral TB that survivesn/a✗✓ SNAC carrier
FDA-approved carrier technology (SNAC)✗✗✓ Ac-SDKP
Gut-targeted~~✓
Tested every batch~✗✓

Comparison of compound delivery architecture only. No efficacy claims implied.

In the literature

Where these compounds appear in peer-reviewed discussion.

Podcasts, long-form video, and researchers discussing the research behind these compound classes.

Verification

Scan it. Open the report.

Every batch is third-party tested. Open the report yourself.

Verify a Batch →

Raw sources

Want the raw research?

Filter by product, ingredient, outcome, study type, and evidence level.

Open Research Library →